Chief Executive Officer
Dr. Karl Hübler was appointed Chief Executive Officer in December 2012.
Karl Hübler has over 20 years of experience in the pharmaceutical and biotech industry. Before joining EUCODIS Bioscience he was Chief Business Development Officer at ACMIT (Austrian Center for Medical Innovation & Technology), an Austrian research center and Business Development Director at Apomedica, a leading Austrian pharmaceutical company. Prior to 2008 he worked in senior management positions in international companies in Europe and in Brazil, where he gained extensive experience in marketing and sales of biotech and pharmaceutical products.
Karl Hübler holds a PhD in Biology from the University of Vienna, Austria.